Immediate Impact

4 by Nobel laureates 7 from Science/Nature 85 standout
Sub-graph 1 of 19

Citing Papers

Systemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: ASCO Guideline Update
2022 Standout
CDK4 and CDK6 kinases: From basic science to cancer therapy
2022 StandoutScience
35 intermediate papers

Works of Xavier Pivot being referenced

The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor–Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy—MONARCH 2
2019 Standout
MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2− Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy
2017 Standout
and 25 more

Author Peers

Author Last Decade Papers Cites
Xavier Pivot 8454 4100 2875 372 11.4k
Joyce O’Shaughnessy 10008 3769 4254 341 13.6k
P. Fumoleau 9431 2609 4272 324 14.0k
Sabino De Placido 7699 4412 3698 376 13.7k
Patrick Neven 8402 4816 4330 486 15.2k
George R. Blumenschein 6894 4981 2383 324 11.7k
Alberto Ocaña 7114 2462 2453 296 12.0k
Jean-­Marc Ferrero 6284 3884 2928 207 9.3k
Luc Dirix 9210 3359 4490 305 14.2k
Christophe Massard 6877 5908 2422 426 12.3k
Sjoerd Rodenhuis 5971 4238 3355 253 12.7k

All Works

Loading papers...

Rankless by CCL
2026